Clinical trial
Effect of SGLT2 Inhibitor on Proteinuria in Diabetic Patients
NCT03573102 is registered in ClinicalTrials.gov with Nahla H Tohami as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of SGLT2 Inhibitor on Proteinuria in Diabetic Patients
- Lead sponsor
- Nahla H Tohami
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- June 20, 2018
- Completion date
- July 31, 2020
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.